SOPH Earnings & Financial Statements
SOPHiA GENETICS S.A.
$7.06
-$0.03(-0.42%)
41
Overall
40
Value
36
Tech
47
Quality
Market Cap
$601.00M
Volume
376.86K
52W Range
$3.75 - $8.98
Target Price
$9.75
SOPH earnings and financial statements: SOPHiA GENETICS S.A.'s income statement, balance sheet and cash flow statement, annual and quarterly.
SOPH Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $77.27M | $65.17M | $62.37M | $47.56M | $40.45M |
| Cost of revenue | $25.19M | $21.24M | $19.46M | -$16.31M | $15.23M |
| Operating income | -$70.91M | -$66.93M | -$74.83M | -$88.20M | -$71.60M |
| EBITDA | -$63.40M | -$58.83M | -$54.31M | -$83.98M | -$70.58M |
| Net income | -$79.00M | -$70.56M | -$62.75M | -$87.45M | -$73.67M |
| EPS (diluted) | $-1.17 | $-0.95 | $-1.22 | $-1.36 | $-1.33 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $163.03M | $155.31M | $206.16M | $243.84M | $320.21M |
| Total liabilities | $115.89M | $58.82M | $54.71M | $43.71M | $60.64M |
| Shareholders’ equity | $47.15M | $96.49M | $151.44M | $172.70M | $259.53M |
| Cash and equivalents | $70.29M | $80.23M | $16.07M | $25.82M | $39.58M |
| Long-term debt | $47.73M | $13.24M | - | $14.05M | $11.25M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$35.89M | -$44.52M | -$48.58M | -$70.09M | -$36.06M |
| Capital expenditure | - | - | - | -$4.56M | -$2.81M |
| Free cash flow | -$36.58M | -$44.95M | -$50.33M | -$74.65M | -$38.87M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SOPH | $7.06 | -0.4% | 376.86K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |